Skip to main content
. 2025 Feb 7;31(5):102249. doi: 10.3748/wjg.v31.i5.102249

Figure 1.

Figure 1

Flow chart depicting the screening of gastric cancer patients who received sintilimab combined with chemotherapy. PD-1: Programmed cell death protein 1; PD-L1: Programmed cell death ligand 1; TyG: Triglyceride glucose.